Patents Assigned to NV reMYND
  • Patent number: 8722681
    Abstract: This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: May 13, 2014
    Assignee: NV reMYND
    Inventors: Gerard Griffioen, Veronica Rojas De La Parra, Annick Lauwers
  • Patent number: 8541406
    Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
    Type: Grant
    Filed: August 6, 2008
    Date of Patent: September 24, 2013
    Assignee: NV reMYND
    Inventors: Gerard Griffioen, Kristel Marie Edith Coupet, Hein Roger Duhamel, Stefaan Wera, Ellen Gommé, Nele Van Damme, Ingrid Van Der Auwera, Marleen Lox, Tom Van Dooren, Tine Decruy
  • Patent number: 7960556
    Abstract: The invention provides novel 1,2,4-thiadiazole derivatives useful for preventing or treating an ?-synucleopathy such as Parkinson's disease, as well as pharmaceutical compositions including them as biologically active ingredients, and methods for manufacturing them.
    Type: Grant
    Filed: November 22, 2007
    Date of Patent: June 14, 2011
    Assignee: NV reMYND
    Inventors: Gerard Griffioen, Stefaan Wera, Hein Roger Duhamel, Ellen Gommé, Nele Van Damme
  • Publication number: 20100261707
    Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
    Type: Application
    Filed: August 6, 2008
    Publication date: October 14, 2010
    Applicant: NV reMYND
    Inventors: Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMME, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY
  • Publication number: 20100197703
    Abstract: This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.
    Type: Application
    Filed: February 5, 2010
    Publication date: August 5, 2010
    Applicant: NV reMYND
    Inventors: Gerard GRIFFIOEN, Veronica ROJAS DE LA PARRA, Annick LAUWERS
  • Publication number: 20090233911
    Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
    Type: Application
    Filed: August 6, 2008
    Publication date: September 17, 2009
    Applicant: NV reMYND
    Inventors: Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMMÉ, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY
  • Publication number: 20090186354
    Abstract: The present invention relates in general to the fields of chemical, pharmaceutical and genetic screening and to diseases associated with protein misfolding. In particular, it discloses engineered cells and a system based thereon that can be used to screen for substances that affect protein misfolding. The engineered cells of the invention comprise one or more reporter genes under transcriptional control of a promoter that is responsive to protein misfolding.
    Type: Application
    Filed: June 1, 2007
    Publication date: July 23, 2009
    Applicant: NV reMYND
    Inventors: Gerard Griffioen, Kristel Marie Edith Coupet, Nele Van Damme, Stefaan Wera
  • Publication number: 20090054410
    Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
    Type: Application
    Filed: August 6, 2008
    Publication date: February 26, 2009
    Applicant: NV reMYND
    Inventors: Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMME, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY